Cocrystal Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cocrystal Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Cocrystal Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.77M, a 1492% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.77M +$1.66M +1492% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.67M +$1.51M +902% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.76M +$1.54M +698% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.85M +$1.58M +576% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $111K -$216K -66.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $167K -$211K -55.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $221K -$207K -48.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $274K -$204K -42.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $327K -$199K -37.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $378K -$25K -6.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $428K -$23K -5.1% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $478K -$20K -4.02% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $526K -$18K -3.31% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $403K -$186K -31.6% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $451K -$183K -28.9% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $498K -$179K -26.4% Dec 31, 2020 10-K 2022-03-23
Q3 2020 $544K -$176K -24.4% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $589K -$172K -22.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $634K -$168K -20.9% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $677K Dec 31, 2019 10-K 2021-03-17
Q3 2019 $720K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $761K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $802K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.